INVITATION FOR TECHNOLOGICAL COOPERATION

Company: HEALFUS LTD.

DOCUMENT STRUCTURE:


CONTACT DATA
Organization: HEALFUS LTD.
Contact: Name: Dr. Roman Liberson
Position: Manager
Address: 12 Ehad Haam St.
Haifa
ISRAEL, 33103
Telephone: 04-8620401 054-7409065
Fax: 04-6709014
Email: rliberson@mail.ru


GENERAL INFORMATION
Established:  2002
Type:  Graduated from technological incubator
Ownership:  Private
Parent:  Kinarot - Jordan Valley Technological Incubator

Core business

Developer of ultrasonic technology for chronic wound treatment.
Low frequency ultrasonic technologies for healing.

Employees:  5
Main Markets:  Hospitals, clinics, private clinics, HMO's , and nursing homes
End users:  Hospital departments include dermatological, orthopedic, traumatological, urological, and surgical treatments

Overview

HealFUS is an R&D company using ultrasonic technology adapted for
a wide array of wound treatment. The company's main goal is to
develop an innovative ultrasonic treatment tip, incorporating
proprietary technology, for the chronic wound market segment.
The product uses low frequency ultrasonic energy, based upon
ultrasonic frequency principles. The specific frequency range,
combined with specially developed treatment tip, enables
intensification of an acoustic effect, using minimal energy. As a
result, any side effects and tissue damage are minimized or
prevented.

Effective wound treatment is achieved by indirect contact between
the treated tissue and the treatment tip. This special tip is
designed and fabricated to ensure continuous liquid media wetting
between the end of the tip and the treated wound. The tip and
accessory configuration serve to create a closed, localized
treatment region, enabling wound treatment in various
orientations, locations, forms, and depth. The combined unit
provides a continuous and fresh liquid media (sterile or
pharmaceutical) to the wound working zone, thereby preventing
recurrence of sonophoresis.

In general, low frequency ultrasonic treatment has several
advantages over existing possible techniques, including:
* Minimal side effects,
* Avoidance of antibiotic resistant culture forming,
* Shorter treatment,
* Cost effectiveness regarding consumables and hospitalization
period
* Low system maintenance
* Operable by nurses and trained staff



Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)

Note - you have to be registered in this server to request information. If you haven't done so yet, please register in this server

Your requests will be forwarded to the developer, who will contact you directly

You can also see the list of documents you already requested more information about


MATIMOP ADDRESS:
Liaison: Mr. Uzi Bar-Sadeh
Internet site: http://www.matimop.org.il
Email: uzi@matimop.org.il
Mail: POBox: 50364 Tel Aviv Israel 61 500
Fax: ++ 972 3 5177655